These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6582584)

  • 21. Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity.
    Einhorn S; Ling P; Einhorn N; Strander H; Wasserman J
    Cancer Immunol Immunother; 1987; 24(3):190-6. PubMed ID: 2954635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogens.
    Einhorn S; Blomgren H; Einhorn N; Strander H
    Clin Exp Immunol; 1983 Feb; 51(2):369-74. PubMed ID: 6839546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
    Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of recombinant human interferon alpha in myelodysplastic syndromes.
    Nand S; Ellis T; Messmore H; Fisher SG; Gaynor E; Fisher RI
    Leukemia; 1992 Mar; 6(3):220-3. PubMed ID: 1564960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired lymphocyte transformation in leukemic patients after intensive therapy.
    Humphrey GB; Nesbit ME; Chary KK; Krivit W
    Cancer; 1972 Feb; 29(2):402-6. PubMed ID: 4501699
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy.
    Spina CA; Fahey JL; Durkos-Smith D; Dorey F; Sarna G
    J Biol Response Mod; 1983; 2(5):458-69. PubMed ID: 6644350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
    Bergsagel DE; Messner H
    Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell activity and ultrastructure in myeloproliferative reactions in infants with Down's syndrome.
    Miale TD; Nasrallah AG; Lobel SA; Demian S; Bowman WP
    Am J Pediatr Hematol Oncol; 1986; 8(3):191-9. PubMed ID: 2945495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.
    Tank B; Marquet RL; Weimar W; Westbroek DL
    Br J Cancer; 1984 Aug; 50(2):227-30. PubMed ID: 6466539
    [No Abstract]   [Full Text] [Related]  

  • 32. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
    O'Connell MJ; Colgan JP; Oken MM; Ritts RE; Kay NE; Itri LM
    J Clin Oncol; 1986 Feb; 4(2):128-36. PubMed ID: 3511183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural cytotoxicity in adult acute leukemia.
    Sørskaar D; Førre O; Albrechtsen D; Stavem P
    Int Arch Allergy Appl Immunol; 1988; 86(2):190-5. PubMed ID: 3292440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cells.
    Ziegler-Heitbrock HW; Erhardt J; Riethmüller G
    Br J Cancer; 1983 Oct; 48(4):507-14. PubMed ID: 6626451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased natural killer cell activity after prolonged administration of interferon in cancer patients.
    Bravo Cuellar A; Martin Ruiz JL; Orbach-Arbouys S
    Immunol Lett; 1985; 10(3-4):137-9. PubMed ID: 4044011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of methimazole on human lymphocyte proliferation and natural killer cell activity.
    Sharma BS; Elias AN
    Gen Pharmacol; 1987; 18(4):449-53. PubMed ID: 3609701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired alpha-interferon production and natural killer activity in blood mononuclear cells in myelodysplastic syndromes.
    Okabe M; Minagawa T; Nakane A; Sakurada K; Miyazaki T
    Scand J Haematol; 1986 Aug; 37(2):111-7. PubMed ID: 3489981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.